Malignant hyperthermia susceptibility (MHS) is a potentially lethal autosomal dominant disorder of skeletal muscle metabolism. Although MHS is rare it remains an important cause of death due to anesthesia. Recently, McCarthy et al. reported a preliminary subregional location for MHS to chromosome 19ql2-l3.2. In addition, MacLennan et al. suggested on the basis of linkage data that a defect in the ryanodine receptor gene (RYDR) causes this disorder. However, genetic heterogeneity has been well described in MHS. We report here extended haplotype analyses with markers in the 19ql3. 113.2 linkage groups that confirms molecular heterogeneity in this disorder. Our data demonstrate that a defect in RYDR could not be responsible for the symptoms of MHS in two unrelated families. The objectives of the current proposal (which will be examined simultaneously) are to evaluate genetic heterogeneity in MHS and evaluate the hormone sensitive lipase (LIPE) as an alternative gene candidate. LIPE is suggested as a gene candidate because it is flanked by the same genetic markers as MHS on 19q. LIPE also regulates free fatty acid (FFA) metabolism, and FFA are abnormally elevated in MHS muscle which may explain many of the observed pathophysiologic findings in this disorder. Therefore, in order to achieve our purposes, we propose (1.) to identify polymorphisms within LIPE and use them in linkage studies to evaluate it as a gene candidate. If no recombinants are identified between LIPE and the MHS phenotype we will evaluate the LIPE cDNA sequence for a defect which causes this disorder. (2.) to evaluate heterogeneity in MHS we will ascertain 50 families, identified by a proband with 2 or more affected sibs which have been phenotyped by the North American Malignant Hyperthermia Group Protocol; (3.) to create a MHS FAMILY DNA RESOURCE available to all investigators by developing immortal cell lines from each individual studied; (4.) to conduct linkage analyses between the MHS phenotype and a complete set of DNA markers on 19q and evaluate if more than one genetic locus produces this disorder and where this gene(s) maps; (5.) to evaluate linkage between the MHS phenotype and DNA polymorphisms on other chromosomes in those families where markers on 19q do not cosegregate with this disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM047145-02
Application #
3306630
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1991-07-01
Project End
1995-06-30
Budget Start
1992-07-01
Budget End
1993-06-30
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Vita, G M; Olckers, A; Jedlicka, A E et al. (1995) Masseter muscle rigidity associated with glycine1306-to-alanine mutation in the adult muscle sodium channel alpha-subunit gene. Anesthesiology 82:1097-103
Levitt, R C; Ewart, S L (1995) Genetic susceptibility to atracurium-induced bronchoconstriction. Am J Respir Crit Care Med 151:1537-42
Fletcher, J E; Tripolitis, L; Hubert, M et al. (1995) Genotype and phenotype relationships for mutations in the ryanodine receptor in patients referred for diagnosis of malignant hyperthermia. Br J Anaesth 75:307-10
Monitto, C L; Levitt, R C; DiSilvestre, D et al. (1995) Localization of the A3 adenosine receptor gene (ADORA3) to human chromosome 1p. Genomics 26:637-8
Schwengel, D A; Jedlicka, A E; Nanthakumar, E J et al. (1994) Comparison of fluorescence-based semi-automated genotyping of multiple microsatellite loci with autoradiographic techniques. Genomics 22:46-54
Jedlicka, A E; Taylor, E W; Meyers, D A et al. (1994) Localization of the highly polymorphic locus D19S120 to 19p13.3 by linkage. Cytogenet Cell Genet 65:140
Levitt, R C; Kiser, M B; Dragwa, C et al. (1994) Fluorescence-based resource for semiautomated genomic analyses using microsatellite markers. Genomics 24:361-5
Schwengel, D A; Nouri, N; Meyers, D A et al. (1993) Linkage mapping of the human thromboxane A2 receptor (TBXA2R) to chromosome 19p13.3 using transcribed 3' untranslated DNA sequence polymorphisms. Genomics 18:212-5
Levitt, R C (1992) Prospects for the diagnosis of malignant hyperthermia susceptibility using molecular genetic approaches. Anesthesiology 76:1039-48
Levitt, R C; Olckers, A; Meyers, S et al. (1992) Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q. Genomics 14:562-6

Showing the most recent 10 out of 14 publications